Study which tests 3 medicines (SB27, EU sourced Keytruda, and US sourced Keytruda) in early or locally advanced non-small cell lung cancer patients who underwent surgery and adjuvant chemotherapy

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-507438-25-00

Acronym

SB27-1005

Enrollment

Registered

2024-01-19

Start date

2024-02-28

Completion date

Unknown

Last updated

2025-08-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-small cell lung cancer

None listed

Sex/Gender

All

Age

18 Years to No maximum

Poland, Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026